Not long ago, ApoC3 polymorphisms were associated with the lean male population’s susceptibility to NAFLD and insulin resistance leading to a rise in ApoC3 plasma levels by approximately 30% and postprandial hypertriglyceridemia caused by ApoC3’s altering effect on lipoprotein lipase activity. The gene discussed is LPL; the disease is Insulin resistance.